Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cohn

Showing results (511-520 of 612) with videos related to

Pageof 62
Sort By:
American Journal of Respiratory and Critical Care Medicine|October 6, 2006
An official ATS statement: hepatotoxicity of antituberculosis therapyJussi J Saukkonen, David L Cohn, Robert M Jasmer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastomaM D Norris, S B Bordow, P S Haber, et al.
Clinical and Translational Science|June 11, 2026
A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in NeuroblastomaLin Xu, Arhanti Sadanand, Evan W Neczypor, et al.
Pediatric Blood & Cancer|June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COGChizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Reply to K. Beiske et alElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2018
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531Clare J Twist, Arlene Naranjo, Mary Lou Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group DatabaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Pediatric Blood & Cancer|November 18, 2020
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group projectLucas Moreno, Dongjing Guo, Meredith S Irwin, et al.
Journal of Pediatric Hematology/Oncology|June 23, 2000
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group StudyC S Alvarado, W B London, A T Look, et al.
Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.
Pageof 62

Showing results (511-520 of 612) with videos related to

Sort By:
Pageof 62
American Journal of Respiratory and Critical Care Medicine|October 6, 2006
An official ATS statement: hepatotoxicity of antituberculosis therapyJussi J Saukkonen, David L Cohn, Robert M Jasmer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastomaM D Norris, S B Bordow, P S Haber, et al.
Clinical and Translational Science|June 11, 2026
A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in NeuroblastomaLin Xu, Arhanti Sadanand, Evan W Neczypor, et al.
Pediatric Blood & Cancer|June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COGChizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Reply to K. Beiske et alElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2018
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531Clare J Twist, Arlene Naranjo, Mary Lou Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group DatabaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Pediatric Blood & Cancer|November 18, 2020
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group projectLucas Moreno, Dongjing Guo, Meredith S Irwin, et al.
Journal of Pediatric Hematology/Oncology|June 23, 2000
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group StudyC S Alvarado, W B London, A T Look, et al.
Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.
Pageof 62